lapatinib has been researched along with 3-methyladenine in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (3-methyladenine) | Trials (3-methyladenine) | Recent Studies (post-2010) (3-methyladenine) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 1,255 | 1 | 904 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Feng, D; Han, T; Jiang, R; Liu, X; Ma, Y; Qiao, H; Wei, Y; Wu, L; Zhang, J; Zhang, S; Zhang, Y; Zhu, X | 1 |
1 other study(ies) available for lapatinib and 3-methyladenine
| Article | Year |
|---|---|
Autophagy stimulates apoptosis in HER2-overexpressing breast cancers treated by lapatinib.
Topics: Adenine; Apoptosis; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Lapatinib; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Signal Transduction | 2013 |